Galetto; Roman

Patent Applications and Registrations

Patent applications and USPTO patent grants for Galetto; Roman.The latest application filed is for "use of pre t alpha or functional variant thereof for expanding tcr alpha deficient t cells".

Company Profile

19.17.34

Galetto; Roman - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells Grant 11,414,674 - Galetto , et al. August 16, 2	2022-08-16
Use Of Pre T Alpha Or Functional Variant Thereof For Expanding Tcr Alpha Deficient T Cells App 20220177914 - GALETTO; Roman ; et al.	2022-06-09
Methods for engineering highly active T cell for immunotherapy Grant 11,311,575 - Galetto , et al. April 26, 2	2022-04-26
Methods for engineering allogeneic and highly active t cell for immunotherapy Grant 11,304,975 - Galetto , et al. April 19, 2	2022-04-19
Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells Grant 11,274,316 - Galetto , et al. March 15, 2	2022-03-15
CD19 specific chimeric antigen receptor and uses thereof Grant 11,077,144 - Galetto , et al. August 3, 2	2021-08-03
Use Of Pre T Alpha Or Functional Variant Thereof For Expanding Tcr Alpha Deficient T Cells App 20210220405 - GALETTO; Roman ; et al.	2021-07-22
Cd123 Specific Chimeric Antigen Receptors For Cancer Immunotherapy App 20210163612 - GALETTO; Roman	2021-06-03
CD19 specific chimeric antigen receptor and uses thereof Grant 11,007,224 - Galetto , et al. May 18, 2	2021-05-18
CD123 specific chimeric antigen receptors for cancer immunotherapy Grant 10,988,541 - Galetto April 27, 2	2021-04-27
Cd19 Specific Chimeric Antigen Receptor And Uses Thereof App 20210060080 - GALETTO; Roman ; et al.	2021-03-04
Cd19 Specific Chimeric Antigen Receptor And Uses Thereof App 20210060079 - GALETTO; Roman ; et al.	2021-03-04
Cd19 Specific Chimeric Antigen Receptor And Uses Thereof App 20210000869 - Galetto; Roman ; et al.	2021-01-07
CD19 specific chimeric antigen receptor and uses thereof Grant 10,874,693 - Galetto , et al. December 29, 2	2020-12-29
Methods For Engineering Allogeneic And Immunosuppressive Resistant T Cell For Immunotherapy App 20200281979 - GALETTO; Roman ; et al.	2020-09-10
Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells Grant 10,517,896 - Galetto , et al. Dec	2019-12-31
Bcma (cd269) Specific Chimeric Antigen Receptors For Cancer Immunotherapy App 20190389959 - GALETTO; Roman	2019-12-26
Cs1 Specific Multi-chain Chimeric Antigen Receptor App 20190359680 - Galetto; Roman	2019-11-28
Use of preTalpha or functional variant thereof for expanding TCRalpha deficient T cells Grant 10,426,795 - Galetto , et al. October 1, 2	2019-10-01
RNA based method to obtain stably integrated retroviral vectors Grant 10,378,026 - Scharenberg , et al. A	2019-08-13
Methods for engineering allogeneic and immunosuppressive resistant T cell immunotherapy Grant 10,363,270 - Galetto , et al.	2019-07-30
Use Of Pre T Alpha Or Functional Variant Thereof For Expanding Tcr Alpha Deficient T Cells App 20190216853 - GALETTO; Roman ; et al.	2019-07-18
Use Of Pre T Alpha Or Functional Variant Thereof For Expanding Tcr Alpha Deficient T Cells App 20190216854 - GALETTO; Roman ; et al.	2019-07-18
Cd19 Specific Chimeric Antigen Receptor And Uses Thereof App 20190209616 - Galetto; Roman ; et al.	2019-07-11
BCMA (CD269) specific chimeric antigen receptors for cancer immunotherapy Grant 10,316,101 - Galetto	2019-06-11
Chimeric antigen receptors targeting B-cell maturation antigen Grant 10,294,304 - Kuo , et al.	2019-05-21
Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells Grant 10,286,007 - Galetto , et al.	2019-05-14
Cd33 Specific Chimeric Antigen Receptors For Cancer Immunotherapy App 20190002561 - GALETTO; Roman	2019-01-03
Cd123 Specific Chimeric Antigen Receptors For Cancer Immunotherapy App 20190002573 - GALETTO; Roman	2019-01-03
Methods For Engineering Allogeneic And Immunosuppressive Resistant T Cell For Immunotherapy App 20180360883 - GALETTO; Roman ; et al.	2018-12-20
Process Of Gene-editing Of Cells Isolated From A Subject Suffering From A Metabolic Disease Affecting The Erythroid Lineage, Cells Obtained By Said Process And Uses Thereof App 20180320138 - SEGOVIA SANZ; Jose Carlos ; et al.	2018-11-08
Cd123 Specific Multi-chain Chimeric Antigen Receptor App 20180134795 - GALETTO; Roman	2018-05-17
CD123 specific chimeric antigen receptors for cancer immunotherapy Grant 9,944,709 - Galetto April 17, 2	2018-04-17
CD33 specific chimeric antigen receptors for cancer immunotherapy Grant 9,944,702 - Galetto April 17, 2	2018-04-17
T Cell Receptor Knock Out Engineered Immune Cells, Endowed With Chimeric Antigen Receptors Binding To Cd123 For The Treatment Of Relapsed/refractory Acute Myeloid Lymphoma Or Blastic Plasmacytoid Dendritic Cell Neoplasm App 20180051089 - GALETTO; Roman ; et al.	2018-02-22
Methods For Engineering Allogeneic And Immunosuppressive Resistant T Cell For Immunotherapy App 20180021379 - GALETTO; Roman ; et al.	2018-01-25
Use Of Pre T Alpha Or Functional Variant Thereof For Expanding Tcr Alpha Deficient T Cells App 20170360835 - GALETTO; Roman ; et al.	2017-12-21
Cd123 Specific Chimeric Antigen Receptors For Cancer Immunotherapy App 20170183413 - GALETTO; Roman	2017-06-29
Cd33 Specific Chimeric Antigen Receptors For Cancer Immunotherapy App 20170145094 - GALETTO; Roman	2017-05-25
Cs1 Specific Multi-chain Chimeric Antigen Receptor App 20170051037 - GALETTO; Roman	2017-02-23
Chimeric Antigen Receptors Targeting B-cell Maturation Antigen App 20160297884 - KUO; TRACY CHIA-CHIEN ; et al.	2016-10-13
Rna Based Method To Obtain Stably Integrated Retroviral Vectors App 20160222410 - SCHARENBERG; Andrew ; et al.	2016-08-04
Cd19 Specific Chimeric Antigen Receptor And Uses Thereof App 20160145337 - GALETTO; Roman ; et al.	2016-05-26
Methods For Engineering Highly Active T Cell For Immunotheraphy App 20160120906 - GALETTO; Roman ; et al.	2016-05-05
Methods For Engineering Allogeneic And Highly Active T Cell For Immunotheraphy App 20160120905 - GALETTO; Roman ; et al.	2016-05-05
Use Of Pre T Alpha Or Functional Variant Thereof For Expanding Tcr Alpha Deficient T Cells App 20150203817 - Galetto; Roman ; et al.	2015-07-23
Methods For Engineering Allogeneic And Highly Active T Cell For Immunotherapy App 20150017136 - GALETTO; ROMAN ; et al.	2015-01-15
Meganuclease Variants Cleaving At Least One Target In The Genome Of A Retrovirus And Uses Thereof App 20140178942 - CHOULIKA; ANDRE ; et al.	2014-06-26
Methods For Engineering Allogeneic And Immunosuppressive Resistant T Cell For Immunotherapy App 20130315884 - Galetto; Roman ; et al.	2013-11-28
Meganuclease Variants Cleaving At Least One Target In The Genome Of A Retrovirus And Uses Thereof App 20120260356 - Choulika; Andre ; et al.	2012-10-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.